Browsing Tag
LP.8.1
4 posts
Can seasonal COVID‑19 shots follow the flu vaccine playbook—and will Americans comply in 2025?
Will Americans embrace annual COVID-19 shots like flu vaccines? Explore how LP.8.1, FDA guidance, and public trust shape the 2025 rollout.
Pfizer and BioNTech secure FDA approval for LP.8.1-adapted COMIRNATY vaccine for high-risk groups
Pfizer and BioNTech's LP.8.1-adapted COVID-19 vaccine gets FDA approval for high-risk groups. Find out what this means for the 2025–2026 rollout season.
Booster drop-off alarms health officials as NB.1.8.1 and LP.8.1 variants gain ground
WHO flags sharp global drop in COVID-19 booster uptake amid rising NB.1.8.1 and LP.8.1 variants; CDC, India, U.K. ramp up fall vaccination planning.
Fall 2025 COVID booster update: FDA endorses JN.1-based vaccine as dominant LP.8.1 strain spreads
FDA backs fall 2025 COVID booster targeting LP.8.1; rollout to begin by August. New vaccine expected to offer stronger protection against dominant variants.